Welch Company
San Francisco, CA
S U M M A R Y
DIARY: December 19, 2010 02:02 PM Sunday;
Rod Welch
VA notified of rising side effects Omeprazole request adjustments.
1...Summary/Objective
..............
Click here to comment!
CONTACTS
SUBJECTS
VA Pharmacy Order Omeprazole Treat Esophagitis Dose Doubled Prescrip
2803 -
2803 - ..
2804 - Summary/Objective
2805 -
280501 - Follow up ref SDS 51 0000. ref SDS 47 0000.
280502 -
280503 -
280504 -
280505 -
280506 -
280508 - ..
2806 -
2807 -
2808 - Background
2809 -
280901 - EGD on 101210, seems to show progress recovering from esophagitis; the
280902 - doctor dilated the LESV from 11 to 14 cm, reported on 101210 0930,
280903 - ref SDS 49 XG6J
280905 - ..
280906 - Follow up EGD planned for February, ref SDS 49 L94L.
280908 - ..
280909 - On 101210 Doctor Lee prescribed doubling dose of Omeprazole to increse
280910 - recover from esophagitis. ref SDS 49 ZN4M
280912 - ..
280913 - On 101216 requested assistance ordering refill for Omeprazole.
280914 - ref SDS 51 K44P
280916 - ..
280917 - On 101218 recognized rising symptoms of side effects caused by
280918 - Omeprazole. ref SDS 52 8Q5I
280920 - ..
280921 - On 101219 1402 submitted letter to medical team reporting rising side
280922 - effects of Omeprazole, ref SDS 0 5N3O, and reqquested adjustments.
280923 -
280924 -
280926 - ..
2810 -
2811 -
2812 - Progress
2813 -
281301 - Letter submitted to the VA saying...
281302 -
281303 - 1. Subject: Omeprazole side effects review dose prescription
281304 - Date: Sun, 19 Dec 2010 14:13:44 -0800
281314 - ..
281315 - 2. Swallowing has improved significantly the past few days,
281316 - following dilation during EGD, and doubling dose for Omeprazole
281317 - on 101210. ref SDS 49 ZN4M
281319 - ..
281320 - 3. Rising symptoms may be side effects of Omeprazole, shown in
281321 - case study listed on 101010. ref SDS 46 11Y4
281323 - ..
281324 - 4. Research yesterday indicates possible correlation with
281325 - Omeprazloe. [...reported on 101218 1642. ref SDS 52 8Q5I...]
281327 - ..
281328 - 5. Please submit analysis of side effects, any adjustments to the
281329 - dose, and remedial measures.
281330 -
281337 -
281338 -
281339 -
281340 -
281341 -
281342 -
281343 -
281344 -
281345 -
281346 -
281347 -
2814 -